Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-21

FDA Approved: NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved a supplemental application for Neomycin sulfate, polymyxin B sulfate, and dexamethasone ophthalmic suspension from Bausch & Lomb. The approval upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neomycin sulfate, polymyxin B sulfate and dexamethasone ophthalmic suspension (Neomycin sulfate; polymyxin B sulfate; dexamethasone)

Snippet

SUPPL AP for NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE)